• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

U1小核核糖核酸介导的严重因子VII缺乏症中mRNA加工的挽救

U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency.

作者信息

Pinotti Mirko, Rizzotto Lara, Balestra Dario, Lewandowska Marzena Anna, Cavallari Nicola, Marchetti Giovanna, Bernardi Francesco, Pagani Franco

机构信息

Department of Biochemistry and Molecular Biology, University of Ferrara, Via Fossato di Mortara 74, Ferrara, Italy.

出版信息

Blood. 2008 Mar 1;111(5):2681-4. doi: 10.1182/blood-2007-10-117440. Epub 2007 Dec 21.

DOI:10.1182/blood-2007-10-117440
PMID:18156490
Abstract

Small nuclear U1-RNAs (snRNAs), the spliceosome components selectively recognizing donor splice sites (5'ss), were engineered to restore correct mRNA processing in a cellular model of severe coagulation factor VII (FVII) deficiency, caused by the IVS7 9726 + 5g/a change. Three U1-snRNAs, complementary to the mutated 5'ss (U1 + 5a) or to neighboring sequences were expressed with FVII minigenes in a hepatoma cell line. The U1-snRNAs reduced from 80% to 40% the exon 7 skipping, thus increasing exon definition. The U1 + 5a construct also dramatically increased recognition of the correct 5'ss over the 37-bp downstream cryptic site preferentially activated by the mutation, thus inducing appreciable synthesis of normal transcripts (from barely detectable to 50%). This effect, which was dose-dependent, clearly demonstrated that impaired recognition by the U1-snRNA was the mechanism responsible for FVII deficiency. These findings suggest compensatory U1-snRNAs as therapeutic tools in coagulation factor deficiencies caused by mutations at 5'ss, a frequent cause of severe defects.

摘要

小核U1-RNAs(snRNAs)是剪接体的组成部分,可选择性识别供体剪接位点(5'ss)。通过基因工程改造,使其在严重凝血因子VII(FVII)缺乏的细胞模型中恢复正确的mRNA加工过程,该模型由IVS7 9726 + 5g/a突变引起。三种与突变的5'ss(U1 + 5a)或相邻序列互补的U1-snRNAs与FVII小基因在肝癌细胞系中共同表达。U1-snRNAs使外显子7跳跃从80%降至40%,从而增强了外显子的界定。U1 + 5a构建体还显著增加了对正确5'ss的识别,超过了由突变优先激活的37bp下游隐蔽位点,从而诱导了正常转录本的可观合成(从几乎检测不到增加到50%)。这种剂量依赖性效应清楚地表明,U1-snRNA识别受损是FVII缺乏的原因。这些发现提示,补偿性U1-snRNAs可作为治疗由5'ss突变引起的凝血因子缺乏的治疗工具,5'ss突变是严重缺陷的常见原因。

相似文献

1
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency.U1小核核糖核酸介导的严重因子VII缺乏症中mRNA加工的挽救
Blood. 2008 Mar 1;111(5):2681-4. doi: 10.1182/blood-2007-10-117440. Epub 2007 Dec 21.
2
How to Design U1 snRNA Molecules for Splicing Rescue.如何设计 U1 snRNA 分子进行剪接救援。
Methods Mol Biol. 2022;2434:89-102. doi: 10.1007/978-1-0716-2010-6_5.
3
Rescue of coagulation factor VII function by the U1+5A snRNA.U1+5A小核仁RNA对凝血因子VII功能的挽救作用
Blood. 2009 Jun 18;113(25):6461-4. doi: 10.1182/blood-2009-03-207613. Epub 2009 Apr 22.
4
U1 snRNA promotes the selection of nearby 5' splice sites by U6 snRNA in mammalian cells.在哺乳动物细胞中,U1小核核糖核酸(snRNA)促进U6小核核糖核酸对附近5'剪接位点的选择。
Genes Dev. 1996 Feb 1;10(3):338-50. doi: 10.1101/gad.10.3.338.
5
High-throughput analysis revealed mutations' diverging effects on exon 7 splicing.高通量分析揭示了突变对第 7 外显子剪接的不同影响。
RNA Biol. 2019 Oct;16(10):1364-1376. doi: 10.1080/15476286.2019.1630796. Epub 2019 Jun 19.
6
Rescue of common and rare exon 2 skipping variants of the GAA gene using modified U1 snRNA.使用修饰的U1小核核糖核酸(snRNA)挽救GAA基因常见和罕见的外显子2跳跃变异体
Mol Med. 2025 Feb 4;31(1):45. doi: 10.1186/s10020-025-01090-z.
7
Informational Suppression to Probe RNA:RNA Interactions in the Context of Ribonucleoproteins: U1 and 5' Splice-Site Base-Pairing.用于探测核糖核蛋白背景下RNA:RNA相互作用的信息抑制:U1与5'剪接位点碱基配对
Methods Mol Biol. 2016;1421:243-68. doi: 10.1007/978-1-4939-3591-8_19.
8
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects.一种外显子特异性 U1 小核 RNA(snRNA)策略来纠正剪接缺陷。
Hum Mol Genet. 2012 Jun 1;21(11):2389-98. doi: 10.1093/hmg/dds045. Epub 2012 Feb 23.
9
Therapeutic strategy to rescue mutation-induced exon skipping in rhodopsin by adaptation of U1 snRNA.通过适配U1小核核糖核酸来挽救视紫红质中突变诱导的外显子跳跃的治疗策略。
Hum Mutat. 2009 Feb;30(2):255-63. doi: 10.1002/humu.20861.
10
Widespread recognition of 5' splice sites by noncanonical base-pairing to U1 snRNA involving bulged nucleotides.非canonical 碱基配对到 U1 snRNA 中的 5' 剪接位点涉及到突环核苷酸,这得到了广泛的认可。
Genes Dev. 2012 May 15;26(10):1098-109. doi: 10.1101/gad.190173.112.

引用本文的文献

1
Rescue of common and rare exon 2 skipping variants of the GAA gene using modified U1 snRNA.使用修饰的U1小核核糖核酸(snRNA)挽救GAA基因常见和罕见的外显子2跳跃变异体
Mol Med. 2025 Feb 4;31(1):45. doi: 10.1186/s10020-025-01090-z.
2
Development of Engineered-U1 snRNA Therapies: Current Status.工程化-U1 snRNA 疗法的开发:现状。
Int J Mol Sci. 2023 Sep 27;24(19):14617. doi: 10.3390/ijms241914617.
3
In Vivo Efficacy and Safety Evaluations of Therapeutic Splicing Correction Using U1 snRNA in the Mouse Retina.体内 U1 snRNA 治疗性剪接校正的疗效和安全性评估在小鼠视网膜中。
Cells. 2023 Mar 21;12(6):955. doi: 10.3390/cells12060955.
4
Exon Skipping Through Chimeric Antisense snRNAs to Correct Retinitis Pigmentosa GTPase-Regulator () Splice Defect.通过嵌合反义 snRNA 外显子跳跃纠正视网膜色素变性 GTP 酶调节剂 () 剪接缺陷。
Nucleic Acid Ther. 2022 Aug;32(4):333-349. doi: 10.1089/nat.2021.0053. Epub 2022 Feb 14.
5
Autosomal dominant optic atrophy: A novel treatment for splice defects using U1 snRNA adaption.常染色体显性遗传性视神经萎缩:一种使用U1小核核糖核酸适配体治疗剪接缺陷的新方法。
Mol Ther Nucleic Acids. 2021 Oct 21;26:1186-1197. doi: 10.1016/j.omtn.2021.10.019. eCollection 2021 Dec 3.
6
Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis.凝血因子 VII 的生化、分子和临床方面及其在止血和血栓形成中的作用。
Haematologica. 2021 Feb 1;106(2):351-362. doi: 10.3324/haematol.2020.248542.
7
Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease.利用纳米技术纠正疾病潜在剪接缺陷的创新治疗与递送方法。
Front Genet. 2020 Jul 14;11:731. doi: 10.3389/fgene.2020.00731. eCollection 2020.
8
Combining Engineered U1 snRNA and Antisense Oligonucleotides to Improve the Treatment of a BBS1 Splice Site Mutation.联合工程化U1小核核糖核酸和反义寡核苷酸以改善对BBS1剪接位点突变的治疗
Mol Ther Nucleic Acids. 2019 Dec 6;18:123-130. doi: 10.1016/j.omtn.2019.08.014. Epub 2019 Aug 16.
9
Splicing Mutations Impairing CDKL5 Expression and Activity Can be Efficiently Rescued by U1snRNA-Based Therapy.剪接突变影响 CDKL5 的表达和活性,可通过 U1snRNA 为基础的治疗方法有效地进行挽救。
Int J Mol Sci. 2019 Aug 24;20(17):4130. doi: 10.3390/ijms20174130.
10
Next-generation sequencing and recombinant expression characterized aberrant splicing mechanisms and provided correction strategies in factor VII deficiency.下一代测序和重组表达技术鉴定了异常剪接机制,并为因子 VII 缺乏症提供了纠正策略。
Haematologica. 2020 Mar;105(3):829-837. doi: 10.3324/haematol.2019.217539. Epub 2019 Jul 4.